What is the anticipated absolute effect of MRA on all-cause mortality in Chronic Heart Failure?
The anticipated absolute effect of MRA on all-cause mortality in Chronic Heart Failure is a relative risk of 792, with the quality of evidence being graded as low due to risk of bias (subgroup), imprecision (from 66 fewer to 6 more). The risk with placebo is reflected by the risk difference with MRA (95% CI).